Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fukui

Showing results (671-680 of 674) with videos related to

Pageof 68
Sort By:
You have reached the last page of results.This site can display upto 674 results.
Gut|December 3, 2005
Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient miceT Fukui, A Nishio, K Okazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 7, 2004
Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal diseaseH Fukui, S Hara, Y Hashimoto, et al.
Journal of Viral Hepatitis|August 15, 2009
Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responsesY Inoue, N Hiramatsu, T Oze, et al.
Clinical Nephrology|September 2, 1998
Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysisK Yoshimoto, S Saima, Y Nakamura, et al.
Pageof 68

Showing results (671-680 of 674) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 674 results.
Gut|December 3, 2005
Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient miceT Fukui, A Nishio, K Okazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 7, 2004
Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal diseaseH Fukui, S Hara, Y Hashimoto, et al.
Journal of Viral Hepatitis|August 15, 2009
Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responsesY Inoue, N Hiramatsu, T Oze, et al.
Clinical Nephrology|September 2, 1998
Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysisK Yoshimoto, S Saima, Y Nakamura, et al.
Pageof 68